ResearcherUniversity of RochesterActive in the last 2 years

Scott Andrew Gerber

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on NIH RePORTER profile ID 10335803. Sources: NIH RePORTER.

Their work

Papers: 0
Trials: 0
Grants: 4
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2023: 1 grant · 2024: none · 2025: 1 grant · 2026: 2 grants

Grants 4

Targeting Intrinsic and Extrinsic Barriers to Treat Metastatic Pancreatic Cancer R01CA295861 ↗
Targeting T Cell Dynamics with IL12mRNA Nanotechnology-Enhanced SBRT to Overcome Immune Suppression in Pancreatic Cancer R01CA300076 ↗
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer R01CA262580 ↗
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer R01CA230277 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Darren R. Carpizo · 1 shared grant, 2026 · strength 1.26
- Grant Targeting Intrinsic and Extrinsic Barriers to Treat Metastatic Pancreatic Cancer R01CA295861 ↗
David C. Linehan · 1 shared grant, 2025 · strength 1.07
- Grant Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer R01CA262580 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.